Avelox
NDC Package 0085-1733-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Avelox is moxifloxacin is used to treat a variety of bacterial infections. Marketed by Schering Plough Corporation, this product is identified by NDC 0085-1733 and is authorized under FDA application NDA021085.

Identification & Billing

NDC Package Code
0085-1733-04
Package Description
1 TABLET, FILM COATED in 1 BOX
Product Code
0085-1733
11-Digit Billing Format
00085173304

Clinical Specifications

Proprietary Name
Avelox
Dosage Form
-
Usage Information
Moxifloxacin is used to treat a variety of bacterial infections. This medication belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Schering Plough Corporation
FDA Application #
NDA021085
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-10-1999
End Marketing Date
07-29-2016
Listing Expiration
07-29-2016
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0085-1733). Click a package code to view its specific billing and regulatory data.

0085-1733-01
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC
0085-1733-02
50 TABLET, FILM COATED in 1 BOX, UNIT-DOSE
0085-1733-03
5 TABLET, FILM COATED in 1 BOX, UNIT-DOSE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0085-1733-04 identifies a specific commercial package of 1 tablet, film coated in 1 box of Avelox, labeled by Schering Plough Corporation. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Schering Plough Corporation on December 10, 1999. The current certification is valid through July 29, 2016.

What are the primary indications for this medication?

Moxifloxacin is used to treat a variety of bacterial infections. This medication belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for virus infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Schering Plough Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00085173304. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0085-1733-04
11-Digit CMS (5-4-2)
00085-1733-04

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.